Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03538327Phase 4Completed
A Phase 4 trial of silibinin in hypertension (HTN), sponsored by University of Magna Graecia. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03538327.